SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
STRATA Skin Sciences Inc (SSKN) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Revisions (C-).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-08-05 | C+ (2.7) | C (2.3) | B- (2.9) | C (2.4) | C- (1.9) | C (2.4) |
| 2026-08-03 | C+ (2.7) | C (2.4) | B- (3.0) | C (2.4) | C- (2.0) | C (2.5) |
| 2026-08-02 | C+ (2.7) | C (2.4) | B- (3.0) | C (2.4) | C- (1.9) | C (2.5) |
| 2026-07-29 | C+ (2.5) | D+ (1.6) | C- (2.1) | F (0.2) | D+ (1.5) | D+ (1.6) |
| 2025-06-30 | C+ (2.6) | D+ (1.6) | C- (2.1) | F (0.2) | D+ (1.5) | D+ (1.6) |